Szybio

Better Biotechnology
Better Life

Szybio

Devoted in research and development
Provide superior products and service

Szybio

COVID-19 Ag Rapid Test kits
Helps contain the COVID-19 spread

ABOUT US

Create a century enterprise
Establish the first brand

Wuhan Life Origin Biotech Joint Stock Co., Ltd. is a high-tech enterprise specialized in the R&D, production and sales of In Vitro diagnostic reagent for clinical medicine.

  • 2009 year

    Founded

  • 36 + million

    Registered capital

  • 20000 +

    Comprehensive Building

  • 700 + person

    Existing staff

PRODUCTS

imgboxbg

Dry Immunofluorescence Analyzer (SZY-H01)

这是描述信息

Lightweight and portable

这是描述信息

Easy to use

这是描述信息

Fast,lab-quality results

这是描述信息

Multiple detection modes

imgboxbg

COVID-19 Antigen One Step Rapid Test (Saliva)

这是描述信息

Can be used for self-test

这是描述信息

No instruments required

这是描述信息

Visually read results in 15 minutes

这是描述信息

Accurate and reliable results

imgboxbg

Dry Immunofluorescence Analyzer (SZY-H01)

这是描述信息

Lightweight and portable

这是描述信息

Easy to use

这是描述信息

Fast,lab-quality results

这是描述信息

Multiple detection modes

imgboxbg

COVID-19 Antigen One Step Rapid Test (Saliva)

这是描述信息

Can be used for self-test

这是描述信息

No instruments required

这是描述信息

Visually read results in 15 minutes

这是描述信息

Accurate and reliable results

  • NEWS CENTER
    2021-12-02
    Good news || Wuhan Life Origin Biotech successfully passed the Rheinland ISO13485 certification
    Wuhan Life Origin Biotech has recently successfully obtained the on-site certification audit of EN ISO13485:2016 by TÜV SÜD, and has received the certificate. This is powerful help for Wuhan Life Origin Biotech to create a global diagnostic testing service!
    Learn more +
  • 2020-05-21
    Wuhan Life Origin Biotech has become a cooperative member of IFCC
    On May 15, 2020, after receiving the notice from the International Federation of clinical chemistry and laboratory medicine (IFCC), Wuhan Life Origin Biotech officially became a cooperative member of IFCC and was the 10th enterprise in China to become a cooperative member of IFCC.
    Learn more +
  • 2019-01-04
    Wuhan Life Origin Biotech won the Intellectual Property Management System Certification
    After winning the "High-tech Enterprise", "Enterprise Technology Center", establishing "Postdoctoral Research Workstation", and "Nobel Prize Laureate Randy Schickman Workstation", Wuhan Life Origin Biotech got the certification of intellectual property management system in December 2018 by its professional R&D team and technological innovation.
    Learn more +
  • 2018-04-02
    Wuhan Life Origin Biotech and Nobel Laureate Professor Randy Schekman set up a Nobel Prize Workstation
    On March 31, 2018, Wuhan Life Origin Biotech and 2013 Nobel Laureate in Physiology or Medicine, Academician of the National Academy of Sciences, and Professor Randy Schekman of the University of California, Berkeley, were in Wuhan East Lake New Technology Development Zone. A signing ceremony was held in the press conference hall of Building 4 of the Public Service Center to jointly build a Nobel Prize Workstation. In this cooperation, Professor Randy Schekman will serve as the chief academic advisor of Wuhan Life Origin Biotech, and provide technical guidance for us. The two parties will invite other units to jointly apply for national major scientific research on the topic of "vesicle diagnostic research and industrialization". subject, and jointly complete the subject research.
    Learn more +
Life Origin Biotech

Address
Wuhan Hi-tech Medical Devices Park, Building B11,#818 Gaoxin Road, Donghu Hi-Tech Development Area, Wuhan, Hubei Province 430206, P.R.China
Telphone
+86-27-87196280

Copyright © 2022 Wuhan Life Origin Biotech Joint Stock Co., Ltd.  鄂ICP备10208809号-1   |    SEO